↓ Skip to main content

Protein Targeting Compounds

Overview of attention for book
Attention for Chapter 3: Protein Targeting Compounds
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Protein Targeting Compounds
Chapter number 3
Book title
Protein Targeting Compounds
Published in
Advances in experimental medicine and biology, January 2016
DOI 10.1007/978-3-319-32805-8_3
Pubmed ID
Book ISBNs
978-3-31-932804-1, 978-3-31-932805-8
Authors

Tomszak, Florian, Weber, Susanne, Zantow, Jonas, Schirrmann, Thomas, Hust, Michael, Frenzel, André, Florian Tomszak, Susanne Weber, Jonas Zantow, Thomas Schirrmann, Michael Hust, André Frenzel

Abstract

Since the development of therapeutic antibodies the demand of recombinant human antibodies is steadily increasing. Traditionally, therapeutic antibodies were generated by immunization of rat or mice, the generation of hybridoma clones, cloning of the antibody genes and subsequent humanization and engineering of the lead candidates. In the last few years, techniques were developed that use transgenic animals with a human antibody gene repertoire. Here, modern recombinant DNA technologies can be combined with well established immunization and hybridoma technologies to generate already affinity maturated human antibodies. An alternative are in vitro technologies which enabled the generation of fully human antibodies from antibody gene libraries that even exceed the human antibody repertoire. Specific antibodies can be isolated from these libraries in a very short time and therefore reduce the development time of an antibody drug at a very early stage.In this review, we describe different technologies that are currently used for the in vitro and in vivo generation of human antibodies.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 5 19%
Student > Ph. D. Student 5 19%
Researcher 5 19%
Student > Bachelor 2 8%
Other 2 8%
Other 1 4%
Unknown 6 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 38%
Agricultural and Biological Sciences 6 23%
Immunology and Microbiology 1 4%
Engineering 1 4%
Unknown 8 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2016.
All research outputs
#20,330,976
of 22,875,477 outputs
Outputs from Advances in experimental medicine and biology
#3,971
of 4,951 outputs
Outputs of similar age
#330,728
of 393,689 outputs
Outputs of similar age from Advances in experimental medicine and biology
#334
of 443 outputs
Altmetric has tracked 22,875,477 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,689 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 443 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.